Avicanna Investor Relations Material
Latest events
Q4 2023
Avicanna
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Avicanna Inc
Access all reports
Avicanna Inc. is a Canadian international commercial-stage biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products. The company operates in the global medical and pharmaceutical market segments, leveraging its established scientific platform, including research and development (R&D) and clinical development. This platform has enabled Avicanna to launch over thirty proprietary products, along with a robust pharmaceutical pipeline aimed at addressing a range of medical conditions. Avicanna's business strategy encompasses active and commercial business pillars that include medical cannabis and wellness products, as well as a medical cannabis care portal. The company is headquartered in Toronto, Canada, and its shares are listed on the Toronto Stock Exchange.
Latest articles
Intel: Semiconductors & Strategic Inflection Points
Founded in 1968, Intel has been a key player in the American semiconductor industry, with its processors powering computers worldwide.
15 Oct 2024
Our Favorite Spin-off Stories Since 2000
Spin-off motives vary widely across different companies, but the underlying objective remains the same: enhancing long-term shareholder value.
17 Oct 2024
Walmart: Walton, Retailing, and Everyday Low Prices
Walmart was founded in 1962 by Sam Walton, and has grown to become the largest retailer in the world, employing more than 2.1 million people worldwide.
17 Oct 2024
Ticker symbol
AVCN
Country
đ¨đŚ Canada